# FDA Inspection 889867 - Biomat USA, Inc - July 28, 2014

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/085f7cda-eefb-4c31-880f-dedd63c074d3
Source feed: FDA_Inspections

> FDA Inspection 889867 for Biomat USA, Inc on July 28, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 889867
- Company Name: Biomat USA, Inc
- Inspection Date: 2014-07-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1122860 - 2020-01-09](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/be84334e-9f15-4038-91d4-037e3d250f4b)
- [FDA Inspection 998944 - 2017-01-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/647014ba-cc0a-464d-8c5d-f431c6330a27)
- [FDA Inspection 719763 - 2011-04-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6ee7fbd6-b3c2-4d2e-904f-02bc6572373c)
- [FDA Inspection 599951 - 2009-07-10](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8c3197a3-848c-423c-8de7-a74350c12ae2)

Company: https://www.keypedia.com/companies/biomat-usa-inc/2ff4120e-f768-441f-b963-cf02221afaa7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d